Immucell (ICCC) Enterprise Value (2016 - 2025)
Immucell's Enterprise Value history spans 16 years, with the latest figure at -$3.8 million for Q4 2025.
- For Q4 2025, Enterprise Value fell 1.29% year-over-year to -$3.8 million; the TTM value through Dec 2025 reached -$3.8 million, down 1.29%, while the annual FY2025 figure was -$3.8 million, 1.29% down from the prior year.
- Enterprise Value reached -$3.8 million in Q4 2025 per ICCC's latest filing, up from -$3.9 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$960347.0 in Q1 2024 to a low of -$11.8 million in Q1 2022.
- Average Enterprise Value over 5 years is -$5.6 million, with a median of -$4.2 million recorded in 2025.
- Peak YoY movement for Enterprise Value: surged 86.83% in 2023, then plummeted 378.93% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$10.2 million in 2021, then soared by 43.14% to -$5.8 million in 2022, then surged by 83.1% to -$978741.0 in 2023, then plummeted by 283.99% to -$3.8 million in 2024, then fell by 1.29% to -$3.8 million in 2025.
- Per Business Quant, the three most recent readings for ICCC's Enterprise Value are -$3.8 million (Q4 2025), -$3.9 million (Q3 2025), and -$6.0 million (Q2 2025).